CYP2B6 c.1294+586G>A

Variant ID: 19-41519306-G-A

NM_000767.4(CYP2B6):c.1294+586G>A

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid.

Southern African Journal Of Hiv Medicine
Decloedt, Eric H EH; Sinxadi, Phumla Z PZ; Wiesner, Lubbe L; Joska, John A JA; Haas, David W DW; Maartens, Gary G
Publication Date: 2021

Variant appearance in text: rs36118214
PubMed Link: 34007475
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs36118214
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



PharmGKB summary: Efavirenz pathway, pharmacokinetics.

Pharmacogenetics And Genomics
McDonagh, Ellen M EM; Lau, Johnathan L JL; Alvarellos, Maria L ML; Altman, Russ B RB; Klein, Teri E TE
Publication Date: 2015-07

Variant appearance in text: CYP2B6: 1294+586G>A; rs36118214
PubMed Link: 25966836
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.

The Journal Of Infectious Diseases
Vardhanabhuti, Saran S; Acosta, Edward P EP; Ribaudo, Heather J HJ; Severe, Patrice P; Lalloo, Umesh U; Kumarasamy, Nagalingeshwaran N; Taulo, Frank F; Kabanda, Joseph J; Oneko, Olola O; Ive, Prudence P; Sambarey, Pradeep P; Chan, Ellen S ES; Hitti, Jane J; Hong, Francis F; McMahon, Deborah D; Haas, David W DW; ,
Publication Date: 2013-08-15

Variant appearance in text: rs36118214
PubMed Link: 23687222
Variant Present in the following documents:
  • Main text
View BVdb publication page